Reshaping the Healthcare Sector Through M&A
The Financial Times, in partnership with Baker McKenzie, are delighted to host this high-level virtual discussion bringing together healthcare corporations, technology companies, and financial investors to explore the ways in which M&A will reshape the sector and fast-track innovation.
KEY TALKING POINTS
How will deal value in the healthcare sector in EMEA change in the coming year? To what extent will the volatile geopolitical context affect foreign investment and block potential deals? |
The COVID crisis has forced businesses to revisit the efficacy and sustainability of business continuity plans and business as usual. How will M&A be used to achieve this? |
|
With the backdrop of rapid and now essential digitisation of the healthcare industry, how can healthcare companies, technology companies and financial investors make a success of M&A in the digital health space? |
Is this fast pace of change we are seeing indicative of a long term shift in the industry or a short term crisis response? Is acceleration happening too fast and should we expect a backlash? |
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice